中国医学创新2024,Vol.21Issue(2) :126-129.DOI:10.3969/j.issn.1674-4985.2024.02.029

甲泼尼龙联合吗啡缓解终末期肺癌呼吸困难的临床观察

Clinical Observation of Methylprednisolone Combined with Morphine in Relieving Dyspnea of End-stage Lung Cancer

周建军
中国医学创新2024,Vol.21Issue(2) :126-129.DOI:10.3969/j.issn.1674-4985.2024.02.029

甲泼尼龙联合吗啡缓解终末期肺癌呼吸困难的临床观察

Clinical Observation of Methylprednisolone Combined with Morphine in Relieving Dyspnea of End-stage Lung Cancer

周建军1
扫码查看

作者信息

  • 1. 泰州市中西医结合医院肿瘤科 江苏 泰州 225300
  • 折叠

摘要

目的:比较甲泼尼龙联合吗啡与单用吗啡缓解终末期肺癌呼吸困难的临床效果.方法:选取泰州市中西医结合医院肿瘤科 2020 年 1 月—2022 年 12 月收治的 80 例终末期肺癌呼吸困难患者,根据不同用药方案将其分为对照组与观察组,每组 40 例.对照组予以吗啡治疗,观察组予以甲泼尼龙联合吗啡治疗.对比两组呼吸困难症状[视觉模拟评分法(VAS)评分]、呼吸困难控制起效时间与维持时间、生命体征(心率、呼吸频率)、血氧饱和度及不良反应(呼吸抑制、嗜睡).结果:治疗后,观察组的VAS评分低于对照组,差异有统计学意义(P<0.05).观察组呼吸困难控制起效时间早于对照组,维持时间长于对照组,差异均有统计学意义(P<0.05).治疗后,观察组的心率、呼吸频率均优于对照组,差异均有统计学意义(P<0.05).治疗后,观察组血氧饱和度高于对照组,差异有统计学意义(P<0.05).观察组不良反应发生率与对照组对比,差异无统计学意义(P>0.05).结论:甲泼尼龙联合吗啡在终末期肺癌呼吸困难患者中的应用效果显著,可明显缓解患者症状,且能稳定其生命体征,提高血氧饱和度水平,不良反应少,有效性与安全性均较好.

Abstract

Objective:To compare the clinical efficacy of Methylprednisolone combined with Morphine and Morphine alone in relieving dyspnea in patients with end-stage lung cancer.Method:A total of 80 patients with dyspnea from end-stage lung cancer admitted to Taizhou City Hospital of Traditional Chinese and Western Medicine from January 2020 to December 2022 were selected,they were divided into a control group and an observation group based on different medication regimens,with 40 cases in each group.The control group was treated with Morphine,and the observation group was treated with Methylprednisolone combined with Morphine.The symptoms of dyspnea[visual analogue scales(VAS)score],onset and maintenance time of dyspnea control,vital signs(heart rate,respiratory rate),blood oxygen saturation and adverse reactions(respiratory depression,lethargy)were compared between the two groups.Result:After treatment,the VAS score in the observation group was significantly lower than that of the control group,the difference was statistically significant(P<0.05).The onset time of dyspnea in the observation group was earlier than that in the control group,and maintenance time was longer than that in the control group,the differences were statistically significant(P<0.05).After treatment,the heart rate and respiratory rate in the observation group were better than those in the control group,the differences were statistically significant(P<0.05).After treatment,the blood oxygen saturation in the observation group was significantly higher than that in the control group,the difference was statistically significant(P<0.05).The incidence of adverse reactions in the observation group was compared with that in the control group,the difference was not statistically significant(P>0.05).Conclusion:The application of Methylprednisolone combined with Morphine in patients with end-stage lung cancer dyspnea has a significant effect,can significantly alleviate the symptoms of patients,stabilize their vital signs,improve the level of blood oxygen saturation,have fewer adverse reactions,and have good efficacy and safety.

关键词

甲泼尼龙/吗啡/终末期肺癌/呼吸困难/生命体征/血氧饱和度

Key words

Methylprednisolone/Morphine/End-stage lung cancer/Dyspnea/Vital signs/Blood oxygen saturation

引用本文复制引用

出版年

2024
中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
参考文献量19
段落导航相关论文